StockData
BIO-TECHNE Corp logo

BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value
$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne operating margin

Operating margin is operating income as a percentage of revenue.

Bio-Techne's operating margin for the twelve months ending Sep 30, 2026 was 19.6%. For fiscal 2026 it was 20.7%, against 8.4% the year before. The highest annual figure on record is 58.1% in fiscal 2010.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2026Jun 30, 202620.7%+12.3
FY2025Jun 30, 20258.4%−9.4
FY2024Jun 30, 202417.8%−8.5
FY2023Jun 30, 202326.3%−0.5
FY2022Jun 30, 202226.8%+1.3
FY2021Jun 30, 202125.5%+4.2
FY2020Jun 30, 202021.3%+0.8
FY2019Jun 30, 201920.5%−0.6
FY2018Jun 30, 201821.2%−0.2
FY2017Jun 30, 201721.4%−8.8
FY2016Jun 30, 201630.2%−2.3
FY2015Jun 30, 201532.5%−12.1
FY2014Jun 30, 201444.7%+44.6
FY2013Jun 30, 20130.1%−52.8
FY2012Jun 30, 201252.8%−3.4
FY2011Jun 30, 201156.2%−1.9
FY2010Jun 30, 201058.1%+1.0
FY2009Jun 30, 200957.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q1 FY2027CQ3 2026Sep 30, 202612.2%−4.4
Q4 FY2026CQ2 2026Jun 30, 202623.1%+30.7
Q3 FY2026CQ1 2026Mar 31, 202624.2%+12.0
Q2 FY2026CQ4 2025Dec 31, 202518.4%+2.4
Q1 FY2026CQ3 2025Sep 30, 202516.6%+2.8
Q4 FY2025CQ2 2025Jun 30, 2025-7.5%−22.5
Q3 FY2025CQ1 2025Mar 31, 202512.2%−9.8
Q2 FY2025CQ4 2024Dec 31, 202416.0%+2.0
Q1 FY2025CQ3 2024Sep 30, 202413.8%−6.4
Q4 FY2024CQ2 2024Jun 30, 202415.0%−16.4
Q3 FY2024CQ1 2024Mar 31, 202422.1%−5.2
Q2 FY2024CQ4 2023Dec 31, 202313.9%−11.1
Q1 FY2024CQ3 2023Sep 30, 202320.2%−0.7
Q4 FY2023CQ2 2023Jun 30, 202331.4%+3.4
Q3 FY2023CQ1 2023Mar 31, 202327.3%−3.9
Q2 FY2023CQ4 2022Dec 31, 202225.0%+1.8
Q1 FY2023CQ3 2022Sep 30, 202220.9%−3.6
Q4 FY2022CQ2 2022Jun 30, 202228.0%+1.5
Q3 FY2022CQ1 2022Mar 31, 202231.1%+3.0
Q2 FY2022CQ4 2021Dec 31, 202123.2%+0.4
Q1 FY2022CQ3 2021Sep 30, 202124.5%+0.5
Q4 FY2021CQ2 2021Jun 30, 202126.5%+4.1
Q3 FY2021CQ1 2021Mar 31, 202128.2%+3.6
Q2 FY2021CQ4 2020Dec 31, 202022.7%+2.7
Q1 FY2021CQ3 2020Sep 30, 202024.0%+5.9
Q4 FY2020CQ2 2020Jun 30, 202022.4%−0.2
Q3 FY2020CQ1 2020Mar 31, 202024.5%+0.7
Q2 FY2020CQ4 2019Dec 31, 201920.0%+0.7
Q1 FY2020CQ3 2019Sep 30, 201918.2%+2.4
Q4 FY2019CQ2 2019Jun 30, 201922.6%−1.2
Q3 FY2019CQ1 2019Mar 31, 201923.9%−2.4
Q2 FY2019CQ4 2018Dec 31, 201819.3%+3.6
Q1 FY2019CQ3 2018Sep 30, 201815.8%−2.2
Q4 FY2018CQ2 2018Jun 30, 201823.8%−1.8
Q3 FY2018CQ1 2018Mar 31, 201826.3%+3.0
Q2 FY2018CQ4 2017Dec 31, 201715.7%+2.1
Q1 FY2018CQ3 2017Sep 30, 201718.0%–
Q4 FY2017CQ2 2017Jun 30, 201725.6%–
Q3 FY2017CQ1 2017Mar 31, 201723.3%–
Q2 FY2017CQ4 2016Dec 31, 201613.6%–

More Bio-Techne figures

See a number that looks wrong?